Form 4 for CRL Charles River Laboratories
Accepted 2026-08-20 16:37:16 ET · period of report 2026-08-19 · accession 0001100682-26-000138 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-20 16:37 | 2026-08-19 | CRL | Girshick Birgit | CEO, Dir | G - Gift | $0.00 | -528 | 35.5K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-19 | G | D | 528 | $0.00 | 35,485 | D | — | — |